A Prospective Study on Efficacy and Safety of Filgrastim (Leuco-Plus 300) for Prevention of Chemotherapy Induced Neutropenia in Patients with Diffuse Large B-Cell Lymphoma
Latest Information Update: 26 Dec 2019
At a glance
- Drugs Filgrastim (Primary)
- Indications Chemotherapy-induced damage; Neutropenia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Siam Bioscience
- 17 Dec 2019 Status changed from active, no longer recruiting to discontinued.
- 07 Oct 2019 Planned number of patients changed from 41 to 20.
- 07 Oct 2019 Status changed from recruiting to active, no longer recruiting.